Answers are grounded in this paper and cite their sources.
In recent times, nanoengineered drug carriers have gained considerable attention in both therapeutic and biomedical fields. The incorporation of biopolymers in synthesizing colloidal nanocarriers has advanced its applications in pharmaceutical research. Carrageenan (CG) is a commonly employed polysaccharide in drug delivery (DD) and biomedical field. It is majorly extracted from the intracellular matrix and cell walls of red seaweeds. Depending on the structural differences, CG is classified into six subtypes, amongst which kappa, lambda, and iota CG are pharmaceutically used. It is also reported to have numerous biological activities. The spatial arrangement in combination with the excellent chemical and physical properties of CG has attributed in the development of novel nanoengineered formulations and scaffolds. The suitable biodegradable and biocompatible nature of CG has aided in the fabrication of various drug carriers. Despite the existing therapeutic and biomedical applications, CG possesses several bioactive properties including antioxidant, antiviral, and antibacterial efficacy. The applications of CG in DD involve oral, brain, skin, and other site-specific DD. The antibacterial efficacy of CG helps in tissue engineering (TE) and wound management. It exhibits potential as a scaffolding material. This review summarizes the source and chemistry of CG along with its therapeutic and biomedical applications.
No takes yet. Share an insight, caveat, or question.
Mukherjee et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: